Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples